Information Provided By:
Fly News Breaks for January 22, 2020
Jan 22, 2020 | 06:36 EDT
Wells Fargo analyst Jacob Hughes upgraded Bausch Health Companies to Equal Weight from Underweight with a $32 price target. The analyst sees "solid" near-term organic growth for Bausch & Lomb and international organic growth. However, he sees this being offset by potential competitive threats to Xifaxan, mixed Sig7 sales trends, and Bausch's debt levels.
News For BHC From the Last 2 Days
There are no results for your query BHC